Professor Daqing Ma (马大青

Professor Daqing Ma, MD, PhD, FRCA, is Professor of Anaesthesia, Macintosh Professor of Royal College of Anaesthetists (RCoA) (2014-16), BOC Chair and Head of Anaesthesia Research of the Section of Anaesthetics, Pain Medicine & Intensive Care, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, and Chelsea and Westminster Hospital. He has more than 220 publications in the English peer reviewed journals (e.g. PNAS, Annals of Neurology, Annals of Surgery, BMJ, JASN, Critical Care Medicine, Anesthesiology and etc.) covering research fields of Anesthesiology, Pharmacology, Neuroscience, Neurology and Nephrology, and two international patents. His main research interests are organoprotection, postoperative cognitive dysfunction, Cancer and Pain. Together with Prof. Nick Franks, FRS, and Prof Mervyn Maze, they are the first to discover its neuroprotective efficacy, and utilising a novel neonatal asphyxia model in rats. They provided valuable insight into the neuroprotective mechanisms of xenon. The key findings facilitated the clinical trial on xenon combined mild hypothermia in hypoxic-ischaemia encephalopathy (HIE) infants. Continueing research neuroprotection, his team found that xenon protects the kidney from ischemia-reperfusion injury, significantly improved short-term graft function and long-term graft survival, by up-regulating the expression of hypoxic inducible factor (HIF) (J Am Soc Nephrol 2009). This research prompted the Medical Research Council, London, considering the role of novel strategy in kidney transplantation, and now entering into the clinical study phase subjected to a funding application. He also pioneered research into the molecular mechanisms of cognitive deterioration following surgery and anaesthesia in the elderly. This work has yielded publications in several high impact factor journals, and were reported in mainstream media, as well as being granted a patent. With an aging population, their knowledge in POCD pathologies and mechanisms would enable the future development of more efficacies treatment. He is board member of British Journal of Anaesthesia, the council member of Anaesthetic Research Society/BJA Forum (UK) and board member of International Chinese Academy of Anaesthesiology since 2012.He is academic editor of PLoS One since 2013, editorial board member of Chinese Journal of Anesthesiology since 2012.He was also elected as the president of Chinese Life Scientists Society. He also took the role of overseas counsellor of Chinese Society of Anesthesiology since 2011.He is the editorial board member of Clinical Journal of Anesthesiology (since 2010) and the chairman of EU COST Action (CA15204) Basic Science (Since 2017). 马大青,医学博士,麻醉学教授, Macintosh and BOC 讲席教授, 博士生导师, 英国皇家麻醉学院院士,帝国理工大学威斯敏斯特医院外科兼肿瘤医学部的麻醉学研究中心主任, 英国麻醉杂志及国际华人麻醉学院董亊和英国华人生命科学家学会主席(http://www.clss.org.uk/)。英国麻醉研究学会常委。他的科学研究得到了MRC、Alzheimer's Society Bupa Foundation、BJA/RCoA、AAGBI、威斯敏斯特医学院研究基金、SPARKS、欧洲麻醉协会等科研基金资助。Anesthesiology、Pharmacology、Neuroscience和Nephrology等领域的国际核心杂志上发表相关领域的著作、论著、综述220余篇 (Lancet, PNAS, BMJ, Annals Neurology, Kidney International, CCM, FASEB J, BJA, Anesthesiology and etc.) (H index 39 and citation > 6,000),并获得国际专利三项。主要研究方向:器官保护、术后认知功能障碍、癌症和疼痛。其研究成果已经得到英国TIMES和每日电讯报在内的多家国际知名传媒和新闻报道的公认。受聘于英国MRC, Wellcome Trust, BBSRC, 瑞士国家科学基金会、克罗地亚共和国科技教育及体育部、中国国家自然科学基金委员会科研项目评审专家和法国AERES专家小组成员, 欧洲COST Action 基础科学委员会主, PLoS One, Journal of Alzheimer's Disease and Brain Science 科学编辑,《中华麻醉学杂志》,《临床麻醉学杂志》、《麻醉和监测论坛》编委与中华医学会麻醉学分会海外顾问, 同时是北京' 千人海聚' 和浙江'千人海鸥”特邀专家。